Search Results 1-10 of 10641 for Clopidogrel
A heart attack or stroke may occur when a blood vessel is blocked by a blood clot. Clopidogrel is a platelet inhibitor. It reduces the chance that a harmful ...
About this study. Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo ...
The traditional approach is to prescribe clopidogrel, the most commonly prescribed antiplatelet therapy, regardless of a person's genetic makeup. However, ...
The purpose of this study is to assess the effectiveness of Clopidogrel for preventing the occurance of transient ischemic attacks (TIA) and minor strokes.
The primary aims of this study are to test the hypothesis that clopidogrel monotherapy is safe following successful PCI among 100 consecutive patients with HBR ...
... clopidogrel, ticagrelor or prasugrel. Patients with coronary artery disease are typically prescribed clopidogrel to reduce the risk of ischemic events, such ...
Clopidogrel is a prodrug, absorbed by the intestine and converted to its active metabolite in the liver via two oxidative steps that involve the cytochrome P450 ...
... clopidogrel use). ... 20 heathy donors and 20 patients maintained on clopidogrel therapy (half on clopidogrel alone and half on both aspirin and clopidogrel ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.